UK Innovation & Science Seed Fund News

Cambridge, UK. 22 June 2011 – Crescendo Biologics Limited (Crescendo) today announces the appointment of Matthew Roe as Chief Business Officer. Matthew joins Crescendo from Genzyme Corporation where he was Senior Director, Business Development & Licensing. During a 23-year career at Genzyme, Matthew was active in licensing, alliance management, acquisition, divestment, and sales and marketing, […]

read more

UK. 12 October 2009 – Mike Romanos has been appointed Chief Scientific Officer of Crescendo Biologics (“Crescendo”) and joins the Board as a Director. Dr Romanos will take leadership of the company and its proprietary antibody fragment technologies following a £4.5 million seed fundraising round led by Sofinnova Partners (see separate announcement). Dr Romanos has […]

read more

1 24 25 26